JP6429782B2 - アルファ−およびガンマ−ｍｓｈアナログ - Google Patents

アルファ−およびガンマ−ｍｓｈアナログ Download PDF

Info

Publication number
JP6429782B2
JP6429782B2 JP2015537289A JP2015537289A JP6429782B2 JP 6429782 B2 JP6429782 B2 JP 6429782B2 JP 2015537289 A JP2015537289 A JP 2015537289A JP 2015537289 A JP2015537289 A JP 2015537289A JP 6429782 B2 JP6429782 B2 JP 6429782B2
Authority
JP
Japan
Prior art keywords
lys
gly
arg
phe
ser
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015537289A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015534972A (ja
JP2015534972A5 (enrdf_load_stackoverflow
Inventor
ベーゼン，トーマス
Original Assignee
ティーエックスピー・ファルマ・ゲーエムベーハー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ティーエックスピー・ファルマ・ゲーエムベーハー filed Critical ティーエックスピー・ファルマ・ゲーエムベーハー
Publication of JP2015534972A publication Critical patent/JP2015534972A/ja
Publication of JP2015534972A5 publication Critical patent/JP2015534972A5/ja
Application granted granted Critical
Publication of JP6429782B2 publication Critical patent/JP6429782B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • C07K14/685—Alpha-melanotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/68—Melanocyte-stimulating hormone [MSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2015537289A 2012-10-19 2013-10-21 アルファ−およびガンマ−ｍｓｈアナログ Active JP6429782B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261716032P 2012-10-19 2012-10-19
US61/716,032 2012-10-19
PCT/EP2013/071935 WO2014060606A1 (en) 2012-10-19 2013-10-21 Alpha- and gamma-msh analogues

Publications (3)

Publication Number Publication Date
JP2015534972A JP2015534972A (ja) 2015-12-07
JP2015534972A5 JP2015534972A5 (enrdf_load_stackoverflow) 2016-12-08
JP6429782B2 true JP6429782B2 (ja) 2018-11-28

Family

ID=49448156

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015537289A Active JP6429782B2 (ja) 2012-10-19 2013-10-21 アルファ−およびガンマ−ｍｓｈアナログ

Country Status (12)

Country Link
US (3) US9217023B2 (enrdf_load_stackoverflow)
EP (2) EP2944650A1 (enrdf_load_stackoverflow)
JP (1) JP6429782B2 (enrdf_load_stackoverflow)
CN (1) CN104822702B (enrdf_load_stackoverflow)
AU (1) AU2013333765B2 (enrdf_load_stackoverflow)
CA (1) CA2888277C (enrdf_load_stackoverflow)
DK (1) DK2722340T3 (enrdf_load_stackoverflow)
ES (1) ES2538702T3 (enrdf_load_stackoverflow)
HU (1) HUE025870T2 (enrdf_load_stackoverflow)
PL (1) PL2722340T3 (enrdf_load_stackoverflow)
RU (1) RU2668791C2 (enrdf_load_stackoverflow)
WO (1) WO2014060606A1 (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017513875A (ja) * 2014-04-22 2017-06-01 ティーエックスピー ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング 分枝状アミノ酸プローブを有するペプチド類似体

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013333765B2 (en) 2012-10-19 2017-12-07 Txp Pharma Gmbh Alpha- and gamma-MSH analogues
WO2015162483A1 (en) * 2014-04-22 2015-10-29 Txp Pharma Gmbh Alpha- and gamma-msh analogues
EP3212220A1 (en) * 2014-10-28 2017-09-06 Clinuvel AG Inflammatory disease
US20170304406A1 (en) * 2014-10-28 2017-10-26 Clinuvel Ag New indication for alpha-msh analogues
WO2017068020A1 (en) 2015-10-20 2017-04-27 Txp Pharma Gmbh W-peptide analog
CN113795250B (zh) 2019-05-10 2024-10-15 西奈克制药有限公司 关节炎疾病的联合治疗
AU2021324066A1 (en) 2020-08-12 2023-03-30 Txp Pharma Ag Exendin-4 peptide analogues
WO2022251650A1 (en) * 2021-05-27 2022-12-01 The Regents Of The University Of Michigan Mc3r agonist peptides
CA3220753A1 (en) 2021-06-21 2022-12-29 Synact Pharma Aps Salts of phenyl pyrrole aminoguanidine and polymorphs of phenyl pyrrole aminoguanidinium salts
EP4565259A2 (en) * 2022-08-03 2025-06-11 Sightstream Biotherapeutics, Inc. Novel melanocortin analogs
CN117106057B (zh) * 2022-08-19 2024-11-01 南京汉欣医药科技有限公司 一种高纯的人促肾上腺皮质激素或其类似物及其规模化制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4356108A (en) 1979-12-20 1982-10-26 The Mead Corporation Encapsulation process
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US5597894A (en) 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
AU5348098A (en) 1996-12-17 1998-07-15 Quadrant Holdings Cambridge Limited Melanocortins
EP1950224A3 (en) * 1998-03-09 2008-12-17 Zealand Pharma A/S Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
SE9801571D0 (sv) 1998-05-05 1998-05-05 Wapharm Ab Melanokortin-1-receptorselektiva föreningar
EP1303625A2 (en) 2000-07-14 2003-04-23 Zycos Inc. Alpha-msh related compounds and methods of use
US8912144B2 (en) 2003-12-16 2014-12-16 Children's Medical Center Corporation Method for treating stroke via administration of NEP1-40 and inosine
CN101257916B (zh) 2005-07-08 2013-04-03 益普生制药股份有限公司 黑皮质素受体配体
NZ566489A (en) * 2005-08-26 2008-10-31 Action Pharma As Therapeutically active alpha-MSH analogues
AU2013333765B2 (en) 2012-10-19 2017-12-07 Txp Pharma Gmbh Alpha- and gamma-MSH analogues
RU2016142145A (ru) 2014-04-22 2018-05-22 ТиЭксПи ФАРМА ГМБХ Пептидные аналоги с разветвленным аминокислотным зондом (зондами)
WO2015162486A1 (en) 2014-04-22 2015-10-29 Txp Pharma Gmbh Linear gamma msh with c- and / or n-terminal extensions of lysine and / or glutamic acid residues
WO2015162483A1 (en) 2014-04-22 2015-10-29 Txp Pharma Gmbh Alpha- and gamma-msh analogues

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017513875A (ja) * 2014-04-22 2017-06-01 ティーエックスピー ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング 分枝状アミノ酸プローブを有するペプチド類似体

Also Published As

Publication number Publication date
US9486495B2 (en) 2016-11-08
CN104822702B (zh) 2019-07-30
BR112015008767A2 (pt) 2017-07-04
JP2015534972A (ja) 2015-12-07
EP2722340A1 (en) 2014-04-23
CA2888277C (en) 2023-09-05
ES2538702T3 (es) 2015-06-23
US9951116B2 (en) 2018-04-24
US20160074469A1 (en) 2016-03-17
HK1197552A1 (en) 2015-01-23
CN104822702A (zh) 2015-08-05
US20170174738A1 (en) 2017-06-22
HUE025870T2 (en) 2016-05-30
AU2013333765B2 (en) 2017-12-07
US20140155328A1 (en) 2014-06-05
WO2014060606A1 (en) 2014-04-24
US9217023B2 (en) 2015-12-22
DK2722340T3 (en) 2015-06-08
RU2015118576A (ru) 2016-12-10
RU2668791C2 (ru) 2018-10-02
AU2013333765A1 (en) 2015-05-28
CA2888277A1 (en) 2014-04-24
EP2722340B1 (en) 2015-03-04
PL2722340T3 (pl) 2015-08-31
EP2944650A1 (en) 2015-11-18

Similar Documents

Publication Publication Date Title
JP6429782B2 (ja) アルファ−およびガンマ−ｍｓｈアナログ
JP5615353B2 (ja) メラノコルチン受容体特異的ペプチド
JP5358564B2 (ja) 環状ペプチドｃｘｃｒ４アンタゴニスト
ES2854353T3 (es) Análogos péptidicos con sonda(s) aminoacídicas ramificadas
CA2530024A1 (en) Melanocortin receptor 4(mc4) agonists and their uses
US20150297672A1 (en) Alpha- and gamma-MSH analogues
US20150376254A1 (en) Gamma-msh analogues
US20230295255A1 (en) Annexin a1-derived polypeptide analogues
US20080242600A1 (en) Backbone Cyclized Melanocortin Stimulating Hormone (Alpha Msh) Analogs
WO2008142319A2 (fr) Analogues peptidiques des recepteurs des melanocortines
WO2017068020A1 (en) W-peptide analog
AU2023226134A1 (en) Annexin a1-derived polypeptide analogues
CA2647114C (en) Amino acid surrogates for peptidic constructs
HK1197552B (en) Alpha- and gamma-msh analogues
BR112015008767B1 (pt) Peptídeo, composição farmacêutica e uso do peptídeo
CN116390938A (zh) 毒蜥外泌肽-4类似物
WO2015019376A1 (en) Synthetic cyclic peptides, agonists and antagonists of urotensin-ii and process for the production thereof

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161020

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161020

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171017

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20171122

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180417

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20181001

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20181030

R150 Certificate of patent or registration of utility model

Ref document number: 6429782

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250